Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study

INTRODUCTION: Acute anterior uveitis (AAU), affecting up to 40% of patients with axial spondyloarthritis (axSpA), risks permanent visual deficits if not adequately treated. We report 2-year results from C-VIEW, the first study to prospectively investigate certolizumab pegol (CZP) on AAU in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst-Bruinsma, Irene E., van Bentum, Rianne E., Verbraak, Frank D., Deodhar, Atul, Rath, Thomas, Hoepken, Bengt, Irvin-Sellers, Oscar, Thomas, Karen, Bauer, Lars, Rudwaleit, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Extra-articular manifestations and comorbidities in spon
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010825/
https://www.ncbi.nlm.nih.gov/pubmed/33854572
http://dx.doi.org/10.1177/1759720X211003803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010825/
https://www.ncbi.nlm.nih.gov/pubmed/33854572
http://dx.doi.org/10.1177/1759720X211003803

Ejemplares similares